Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference Total Health | Oncology 26:08 1 year ago 3 797 Скачать Далее
HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference Total Health | Oncology 25:20 1 year ago 2 075 Скачать Далее
Adjuvant Therapy | 2023 KU Breast Cancer Year in Review Conference Total Health | Oncology 30:22 1 year ago 919 Скачать Далее
Metastatic Breast Cancer | 2022 OneOncology Conference Total Health | Oncology 26:14 1 year ago 1 932 Скачать Далее
Sequencing Treatment Options in HER2 Positive Breast Cancer: 2023 Best of Breast Conference Total Health | Oncology 2:43 1 year ago 4 098 Скачать Далее
2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy Total Health | Oncology 31:32 2 years ago 1 449 Скачать Далее
Metastatic Triple Negative Breast Cancer: 2023 Best of Breast Conference Total Health | Oncology 2:25 1 year ago 4 730 Скачать Далее
2022 West Oncology Conference | Breast Cancers | Metastatic Total Health | Oncology 22:57 2 years ago 717 Скачать Далее
Updates in Metastatic Breast Cancer: 2023 West Oncology Total Health | Oncology 1:34 1 year ago 534 Скачать Далее
Historical Perspective on HR+/HER2- Breast Cancer: 2023 KU Breast Cancer Year in Review Total Health | Oncology 5:19 1 year ago 494 Скачать Далее
2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches Total Health | Oncology 30:10 2 years ago 1 622 Скачать Далее
Adjuvant Therapy | 2023 Best of Breast Conference Total Health | Oncology 46:31 1 year ago 5 940 Скачать Далее
Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment Strategies Total Health | Oncology 25:14 3 years ago 1 126 Скачать Далее
Lightning Updates | 2023 Best of Breast Conference Total Health | Oncology 20:55 1 year ago 2 196 Скачать Далее
How to use endocrine therapy in premenopausal women with ER+ metastatic breast cancer European Society for Medical Oncology (ESMO) 4:22 4 years ago 2 581 Скачать Далее
Current state of CDK4/6 inhibitors in metastatic HER2-negative breast cancer VJOncology 1:25 8 months ago 305 Скачать Далее
Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancer European Society for Medical Oncology (ESMO) 4:50 1 year ago 1 330 Скачать Далее
2022 West Oncology Conference | Precision Oncology in HR+ Breast Cancer Total Health | Oncology 23:51 2 years ago 2 353 Скачать Далее
Preserving Fertility, and Genomic Assays in Breast Cancer: 2023 KU Breast Cancer Year in Review Total Health | Oncology 2:23 1 year ago 36 Скачать Далее
Investigating targeted therapy combinations in metastatic HR+ breast cancer VJOncology 3:15 1 year ago 611 Скачать Далее
